波士顿科学涨超 4.4%，Q3 业绩超预期 + 上调全年调整后盈利指引

Medical device company Boston Scientific rose over 4.4%, closing at $104.36. On the news front, Boston Scientific's third-quarter sales increased by 20% year-on-year to $5.07 billion, exceeding Wall Street analysts' expectations of $4.97 billion. Among them, the cardiovascular division's sales grew by 22% year-on-year to $3.34 billion, higher than the expected $3.27 billion. During the period, the adjusted earnings per share were $0.75, above the expected $0.71. The company raised its full-year adjusted earnings per share guidance to $3.02 to $3.04, surpassing analysts' expectations of $2.98